Inventor
SABBADINI ROGER A
US33 patents
⚠️ This page may combine multiple inventors who share the name “SABBADINI ROGER A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SABBADINI ROGER A
17 patentsUS8524484B2Sep 3, 2013
Immunogenic minicells and methods of use
SABBADINI ROGER A27 citations92
US8129166B2Mar 6, 2012
Immunogenic minicells and methods of use
SABBADINI ROGER A19 citations91
US8101396B2Jan 24, 2012
Minicells displaying antibodies or derivatives thereof and comprising biologically active compounds
SABBADINI ROGER A27 citations91
US8614103B2Dec 24, 2013
Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions
SABBADINI ROGER A6 citations81
US8158124B2Apr 17, 2012
Compositions and methods for binding lysophosphatidic acid
SABBADINI ROGER A10 citations81
US8067549B2Nov 29, 2011
Humanized antibodies and compositions for binding sphingosine-1-phosphate
SABBADINI ROGER A4 citations73
US8604172B2Dec 10, 2013
Humanized antibody compositions and methods for binding lysophosphatidic acid
SABBADINI ROGER A5 citations72
US9274130B2Mar 1, 2016
Prevention and treatment of pain using antibodies to lysophosphatidic acid
SABBADINI ROGER A4 citations67
US8871202B2Oct 28, 2014
Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
SABBADINI ROGER A2 citations63
US8796429B2Aug 5, 2014
Bioactive lipid derivatives, and methods of making and using same
SABBADINI ROGER A2 citations62
US8222373B2Jul 17, 2012
Humanized antibodies and compositions for binding sphingosine-1-phosphate
SABBADINI ROGER A1 citations62
US8444970B2May 21, 2013
Compositions and methods for treating ocular diseases and conditions
SABBADINI ROGER A2 citations60
US9217749B2Dec 22, 2015
Immune-derived moieties reactive against lysophosphatidic acid
SABBADINI ROGER A1 citations52
US9163091B2Oct 20, 2015
Compositions and methods for binding lysophosphatidic acid
SABBADINI ROGER A0 citations45
US9274129B2Mar 1, 2016
Methods and reagents for detecting bioactive lipids
SABBADINI ROGER A0 citations41
US8401799B2Mar 19, 2013
Antibody design using anti-lipid antibody crystal structures
SABBADINI ROGER A1 citations40
US9181331B2Nov 10, 2015
Pharmaceutical compositions for binding sphingosine-1-phosphate
SABBADINI ROGER A0 citations35
LPATH INC
8 patentsUS7829674B2Nov 9, 2010
Compositions and methods for binding sphingosine-1-phosphate
LPATH INC20 citations91
US7901682B2Mar 8, 2011
Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation
LPATH INC9 citations84
US8025877B2Sep 27, 2011
Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate
LPATH INC5 citations73
US8026342B2Sep 27, 2011
Compositions and methods for binding sphingosine-1-phosphate
LPATH INC2 citations61
US7862812B2Jan 4, 2011
Methods for decreasing immune response and treating immune conditions
LPATH INC1 citations52
US7956173B2Jun 7, 2011
Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate
LPATH INC0 citations51
US7794713B2Sep 14, 2010
Compositions and methods for the treatment and prevention of hyperproliferative diseases
LPATH INC0 citations45
US8361465B2Jan 29, 2013
Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
LPATH INC0 citations41
VAXIION THERAPEUTICS INC
3 patentsUS7183105B2Feb 27, 2007
Eubacterial minicells and their use as vectors for nucleic acid delivery and expression
VAXIION THERAPEUTICS INC90 citations98
US7871815B2Jan 18, 2011
Rhamnose-inducible expression constructs and methods
VAXIION THERAPEUTICS INC14 citations92
US7396822B2Jul 8, 2008
Immunogenic minicells and methods of use
VAXIION THERAPEUTICS INC12 citations82